Login
← Go Back
Dr. Reddy's Laboratories
DRREDDY · Pharma > Pharmaceuticals & Drugs · Chairman: K Satish Reddy · MD: GV Prasad · Listing date: Oct. 24, 1994 · Employees: 22739 · Hyderabad · http://www.drreddys.com
Stock Price vs Company Growth
1d
0.6%
1w
5.2%
1m
3.4%
3m
6.8%
6m
16.1%
1y
28.0%
5y
17.5%
10y
9.8%
all
13.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 6,253 0.6%
5,741
6,506
Company Overview
Sales
27,212 Cr
Growth: 14.7%
Profit after Tax
5,228 Cr
Growth: 2.7%
Large Cap
1,04,316 Cr
P/E: 19.9x
Industry P/E: 35.5x
Fundamentals
Sales (Cr) ₹ 27,212
Growth 14.7%
EBITDA 28.0%
P/S 3.8x
Dividend 0.8%
P/E 19.9x
Book Value ₹ 1,652
PEG Ratio 1.4x
ROE 20.6%
P/B 3.8x
Shareholding Pattern
Institutions
First Senter Investors Icvc- Stewart Investors Asia Pacific Leaders Sustainability Fund
3.37 %
Life Insurance Corporation Of India P & Gs Fund
2.34 %
Sbi Mutual Fund
2.11 %
Aditya Birla Mutual Fund
1.96 %
Government Of Singapore - E
1.77 %
Promoters
Dr. Reddy'S Holdings Limited
24.84 %
Gunupati Venkateswara Prasad (Huf)
0.67 %
Samrajyam Reddy Kallam
0.67 %
Satish Reddy Kallam
0.54 %
Others
Jp Morgan Chase Bank, Na
12.09 %
Icici Prudential Life Insurance Company Limited
1.38 %
Nps Trust - A/C
1.27 %
Iepf
0.14 %
Increase    Decrease    No change
Company Profile Detailed
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
Belongs to (40 Indices) view more
Investors (379)
iepf
aditya.b...
delores....
Followers (32)
manzoor
talent
apurv